日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

NFE2 and PF4 as biomarkers for BET inhibition-induced thrombocytopenia in preclinical and clinical studies.

NFE2 和 PF4 作为 BET 抑制剂引起的血小板减少症的临床前和临床研究的生物标志物

Zhang Cindy, Xu Ke, Wang Faye, Price Jennifer, Panzica Julie, Coker Shodeinde, Esposito Oriana, Greenawalt Danielle, Westhouse Richard, Augustine-Rauch Karen

TGFβ2 and TGFβ3 mediate appropriate context-dependent phenotype of rat valvular interstitial cells

TGFβ2 和 TGFβ3 介导大鼠瓣膜间质细胞适当的、依赖于环境的表型。

Wang, Faye; Zhang, Cindy; Kwagh, Jae; Strassle, Brian; Li, Jinqing; Huang, Minxue; Song, Yunling; Lehman, Brenda; Westhouse, Richard; Palanisamy, Kamalavenkatesh; Holenarsipur, Vinay K; Borzilleri, Robert; Augustine-Rauch, Karen

Discovery of BMS-986260, a Potent, Selective, and Orally Bioavailable TGFβR1 Inhibitor as an Immuno-oncology Agent

发现强效、选择性强且口服生物利用度高的TGFβR1抑制剂BMS-986260,可作为免疫肿瘤药物

Velaparthi, Upender; Darne, Chetan Padmakar; Warrier, Jayakumar; Liu, Peiying; Rahaman, Hasibur; Augustine-Rauch, Karen; Parrish, Karen; Yang, Zheng; Swanson, Jesse; Brown, Jennifer; Dhar, Gopal; Anandam, Aravind; Holenarsipur, Vinay K; Palanisamy, Kamalavenkatesh; Wautlet, Barri S; Fereshteh, Mark P; Lippy, Jonathan; Tebben, Andrew J; Sheriff, Steven; Ruzanov, Max; Yan, Chunhong; Gupta, Anuradha; Gupta, Arun Kumar; Vetrichelvan, Muthalagu; Mathur, Arvind; Gelman, Marina; Singh, Rajinder; Kinsella, Todd; Murtaza, Anwar; Fargnoli, Joseph; Vite, Gregory; Borzilleri, Robert M

Discovery of 4-Azaindole Inhibitors of TGFβRI as Immuno-oncology Agents

发现 4-氮杂吲哚类 TGFβRI 抑制剂作为免疫肿瘤药物

Zhang, Yong; Zhao, Yufen; Tebben, Andrew J; Sheriff, Steven; Ruzanov, Max; Fereshteh, Mark P; Fan, Yi; Lippy, Jonathan; Swanson, Jesse; Ho, Ching-Ping; Wautlet, Barri S; Rose, Anne; Parrish, Karen; Yang, Zheng; Donnell, Andrew F; Zhang, Liping; Fink, Brian E; Vite, Gregory D; Augustine-Rauch, Karen; Fargnoli, Joseph; Borzilleri, Robert M